# Multi-center Study to Transplant Hepatitis-C Infected Kidneys

> **NCT03781726** · PHASE4 · COMPLETED · sponsor: **Raymond Chung** · enrollment: 30 (actual)

## Conditions studied

- Renal Failure Chronic
- Hepatitis C

## Interventions

- **DRUG:** glecaprevir/pibrentasvir treatment

## Key facts

- **NCT ID:** NCT03781726
- **Lead sponsor:** Raymond Chung
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2020-03-20
- **Final completion:** 2021-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781726, "Multi-center Study to Transplant Hepatitis-C Infected Kidneys". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03781726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*